Offsetting this, it had us$150.2m in cash and us$103.0k in receivables that were due within 12 months. Private updated dec 3, 2021 11:28 pm gmda.
Gamida cell (gmda) has been upgraded to a zacks rank #2 (buy), reflecting growing optimism about the company's earnings prospects.
Gamida cell stock news. So far 824,074 shares have traded compared to average volume of 278,623 shares. (gmda) stock quote, history, news and other vital information to help you with your stock trading and investing. Gmda | complete gamida cell ltd.
The stock opened with a gain of 14.94% at $2.77 and touched an intraday high of $2.8100, rising 16.60% against the last close of $2.41. This might drive the stock higher in the near term. A downtrend has been apparent in gamida cell (.
November 4, 2021 at 9:00 am edt. Needham adjusts price target on gamida cell to $12 from $14, keeps buy rating. Gamida cell announces pricing of initial public offering.
So it can boast us$27.7m more liquid assets than total liabilities. Oppenheimer adjusts gamida cell pt. While the stock has lost 6.3% over the past week, it could witness a trend reversal as a hammer chart.
Find the latest gamida cell ltd. Gamida cell ltd (gmda) stock is trading at $3.58 as of 1:47 pm on friday, nov 12, a rise of $0.06, or 1.7% from the previous closing price of $3.52. Zooming in on the latest balance sheet data, we can see that gamida cell had liabilities of us$22.6m due within 12 months and liabilities of us$100.0m due beyond that.
Taking a look at stock we notice that its last check on previous day was $3.96 and 5y monthly beta was reading 1.91 with its price kept floating in th The stock went to a low of $2.7000 during the session. This suggests a possible upside of 518.6% from the stock's current price.
Their forecasts range from $11.00 to $22.00. Gamida cell announces publication in blood, the journal of the american society of hematology, of the first pivotal trial to evaluate a cell therapy (omidubicel) for patients with blood cancer who require an allogeneic stem cell transplant read more Gamida cell (gmda) moves to buy:
Volume today is above average. The investor relations website contains information about gamida cell ltd.'s business for stockholders, potential investors, and financial analysts. Gamida cell announces data to be presented at 63rd ash annual meeting.
Gmda), an advanced cell therapy company committed to cures for cancer and other serious diseases, today announced four presentations at the 63 rd. Rbc capital thinks gamida cell’s stock is going to recover. Get the latest gamida cell stock price and detailed information including gmda news, historical charts and realtime prices.
The stock has traded between $3.27 and $3.65 so far today. On average, they expect gamida cell's share price to reach $14.60 in the next year.
